(Q33795297)

29 July 2017

1 reference

title

The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders (English)

1 reference

29 July 2017

1 reference

0 references

Heim C

1

1 reference

PubMed ID

10599479

29 July 2017

Nemeroff CB

series ordinal

2

1 reference

PubMed ID

10599479

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

29 July 2017

Biological Psychiatry

1 reference

29 July 2017

46

1 reference

29 July 2017

1509-1522

1 reference

29 July 2017

11

1 reference

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The oCRH stimulation test before and after clinical recovery from depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Elevated CSF CRF in suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The role of corticotropin-releasing factor in depression and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Hypercortisolemia and hippocampal changes in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Cerebrospinal fluid neuropeptides in mood disorder and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Impact of child sexual abuse: a review of the research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The hypothalamic-pituitary-adrenal system in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The dexamethasone suppression test in patients with primary obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

CSF corticotropin-releasing factor is not affected in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The prediction of major depression in women: toward an integrated etiologic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Stressful life events, genetic liability, and onset of an episode of major depression in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Pituitary size in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Protective and damaging effects of stress mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The long-term impact of the physical, emotional, and sexual abuse of children: a community study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Adrenal gland enlargement in major depression. A computed tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

A troubled youth: relations with somatization, depression and anxiety in adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The effects of varying environmental demands on maternal and infant behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The dexamethasone suppression test in panic disorder: comparison with normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Allostasis, amygdala, and anticipatory angst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The dexamethasone suppression test in generalised anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Hippocampal atrophy in recurrent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing factor modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The corticotropin-releasing hormone test in patients with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Abnormal noradrenergic function in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Hippocampal volume in women victimized by childhood sexual abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Early vs. late maternal deprivation differentially alters the endocrine and hypothalamic responses to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

The Brown Norway rat displays enhanced stress-induced ACTH reactivity at day 18 after 24-h maternal deprivation at day 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Increased pituitary activation following metyrapone administration in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Childhood abuse experiences and combat-related PTSD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Childhood abuse and recovery from major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

Childhood adversities and adult depression: basic patterns of association in a US national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Long-term behavioral and neuroendocrine adaptations to adverse early experience

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900224-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00224-3

1 reference

29 July 2017

1 reference

PubMed ID

10599479